Obesity drug failing patients due to lack of education about side-effects

A new study, published today in the Journal of Health Psychology, found that patients who gained weight 18 months after taking Orlistat attributed their weight-loss failure either to the side effects which have prevented them from sticking to the medication or felt that the medication simply had not worked.

The team from the University of Surrey also found that participants described a series of barriers to including psychological and , relationships and the make-up of their bodies. They also described a number of alternative methods of weight loss that had also failed, and the failure of Orlistat was included within this idea of permanent and ongoing failure.

Orlistat is currently the only prescribed drug for obesity and functions by reducing the amount of fat absorbed from food eaten.

"Our results have significant implications for GPs and how they should communicate with the patients about this drug," said lead author Dr Amelia Hollywood from the University of Surrey.

"GPs can improve patient support while taking Orlistat. At present, the so called "side effects" of Orlistat are seen as unpleasant and intrusive. If health professionals can highlight that such "side effects" are actually the consequences of eating high-fat foods while taking the drug, it could help ensure a change in diets.

"In addition, by alerting patients to these consequences and emphasising the need for dietary change, patients may be in a better position to make an informed judgement as to whether they wish to be prescribed this medication. GPs may likewise be able to make a more informed decision as to whether the medication should be prescribed, which could have cost implications for the NHS by reducing the waste of medications."

add to favorites email to friend print save as pdf

Related Stories

Low-carb diet effective at lowering blood pressure

Jan 25, 2010

In a head-to-head comparison, two popular weight loss methods proved equally effective at helping participants lose significant amounts of weight. But, in a surprising twist, a low-carbohydrate diet proved better at lowering ...

Fatty liver disease medication may have no effect

Jan 13, 2009

A new randomized, prospective trial has shown that orlistat, a commonly prescribed inhibitor of fat absorption, does not help patients with fatty liver disease (FLD) lose weight, nor does it improve their liver enzymes or ...

Recommended for you

Gut bacteria promote obesity in mice

Sep 30, 2014

A species of gut bacteria called Clostridium ramosum, coupled with a high-fat diet, may cause animals to gain weight. The work is published this week in mBio, the online open-access journal of the American Society for Microbiol ...

An apple a day could keep obesity away

Sep 29, 2014

Scientists at Washington State University have concluded that nondigestible compounds in apples – specifically, Granny Smith apples – may help prevent disorders associated with obesity. The study, thought ...

Boosting purchasing power to lower obesity rates

Sep 25, 2014

In January, as one of the first major initiatives of the Academic Vision, the Rudd Center for Food Policy and Obesity will move to UConn from Yale University. The move will allow Rudd faculty to expand their work and build ...

Note to young men: Fat doesn't pay

Sep 23, 2014

Men who are already obese as teenagers could grow up to earn up to 18 percent less than their peers of normal weight. So says Petter Lundborg of Lund University, Paul Nystedt of Jönköping University and ...

Waistlines of US adults continue to increase

Sep 16, 2014

The prevalence of abdominal obesity and average waist circumference increased among U.S. adults from 1999 to 2012, according to a study in the September 17 issue of JAMA.

User comments